Menopause Symptom Tracker

Hot flashes and night sweats: tracking count and severity separately

The tracker separates Hot Flashes Today as a count from Flash Severity on a 0-to-10 scale and Night Sweats on a 0-to-10 scale. This separation matters clinically. Someone who has 12 mild hot flashes per day is in a different symptom situation than someone who has 4 severe, disruptive ones. Both need clinical attention, but the nature of the management conversation differs.

Night sweats are tracked separately from hot flashes because their impact is largely on sleep architecture rather than on daytime function. A person with severe night sweats and mild daytime flashes has their symptom burden concentrated in the sleeping hours, which affects treatment approaches differently than someone whose vasomotor symptoms are primarily daytime.

Track the count of hot flashes as accurately as you can. On high-frequency days, use a tally approach during the day rather than trying to reconstruct the count in the evening. The daily average over four weeks is what your provider most needs to see.

Sleep quality and the sleep disruption cycle in menopause

Sleep Quality on a 1-to-10 scale is one of the highest-weight fields in the tracker because disrupted sleep is both a direct menopause symptom (from night sweats) and a multiplier of every other symptom category. Poor sleep intensifies mood disruption, brain fog, anxiety, and even hot flash frequency in many people.

The interaction between night sweats and sleep quality is worth watching explicitly in your weekly chart. Many people discover that their most symptom-dense days reliably follow their worst sleep nights, with night sweat severity as the mediating variable. This sleep-symptom loop is one of the most tractable treatment targets in menopause care: addressing night sweats often improves sleep, which improves daytime mood and cognitive function simultaneously.

Share the sleep and night sweat trend together at your next provider appointment. The two variables together tell a much more specific story than either does alone.

Mood, anxiety, and brain fog: the underreported symptom cluster

Mood Changes on a 1-to-10 scale, Anxiety on a 0-to-10 scale, and Brain Fog on a 0-to-10 scale capture the cognitive and emotional symptom cluster of menopause that is frequently underreported at medical appointments because it feels subjective or because it overlaps with depression and anxiety diagnoses.

Menopausal mood and cognitive symptoms are physiologically distinct from primary anxiety or depression, though they can coexist with them and are often misdiagnosed as one or the other. Tracking them consistently alongside vasomotor symptoms (hot flashes and night sweats) helps your provider see whether these symptoms correlate with the hormonal fluctuation pattern rather than appearing independently.

If you have been told your mood symptoms are depression or anxiety unrelated to menopause, your tracked data showing clear correlation with hot flash frequency and menopause stage is worth presenting for reevaluation.

Joint pain: the frequently missed menopause symptom

Joint Pain on a 0-to-10 scale appears in this tracker because musculoskeletal symptoms including joint pain, stiffness, and muscle aches are common in perimenopause and menopause but are often attributed to aging rather than hormonal changes. For some people, joint pain is a significant part of their menopause symptom burden that affects daily function and is worth documenting.

Tracking joint pain alongside vasomotor and sleep symptoms helps establish whether it is part of the same fluctuation pattern or a separate concern. If joint pain rises significantly alongside hot flash and mood symptoms, the correlation is clinically useful. If it follows a different pattern entirely, that is also worth noting for your provider.

Treatment Effect: rating your relief to know when it is time to adjust

Treatment Effect on a 0-to-10 scale asks how much your current treatment is reducing your symptom burden. Whether you are using hormone therapy, non-hormonal prescription options, phytoestrogen supplements, lifestyle modifications, or managing without treatment, rating the effect daily gives you and your provider a running assessment of whether the current approach is sufficient.

A Treatment Effect score that consistently sits at 3 or below despite several months of a given treatment is a clear signal that adjustment is warranted. Bring the trend to your provider with your symptom scores alongside it: the symptom scores show what you are still experiencing, and the treatment effect score shows how much the current approach is helping. That combination is a much more specific basis for a treatment conversation than a verbal summary. Four weeks of data, printed and handed over, tells the whole story. Track 90 days of symptoms + sleep to bring concrete frequency + severity data to your menopause discussion → Track 90 days of symptoms + sleep to bring concrete frequency + severity data to your menopause discussion →

Important: this is a self-tracking tool, not medical advice

This tracker is a self-monitoring tool, not a diagnostic device. The information you enter and the scores it produces are for personal awareness and for sharing with your clinician — they are not a substitute for professional medical evaluation, diagnosis, or treatment. Do not change medication, dose, or treatment plan based on this tool. If you experience symptoms that concern you, contact your clinician; for emergencies in the US, call 911 or your local emergency number. Mental health crisis support in the US is available 24/7 by calling or texting 988.

Menopause Symptom Tracker vs. the alternatives

How to use it

1. Count Hot Flashes Today as accurately as possible during the day and rate their Severity from 0 to 10.
2. Rate Night Sweats and Sleep Quality for the previous night, noting how much sleep disruption occurred.
3. Score Mood Changes and Anxiety from 0 to 10 based on the full day, and rate Brain Fog on the same scale.
4. Rate Joint Pain from 0 to 10 and select your current Menopause Stage and Treatment type.
5. Rate Treatment Effect from 0 to 10 based on how much your current approach is reducing your overall symptom experience.
6. Track for four consecutive weeks and print the symptom summary for your next gynecology or menopause specialist appointment.

Who it's for

• Person deciding whether to start hormone therapy — Someone tracking their symptoms for six weeks discovers an average of 9 hot flashes daily at severity 7 plus sleep quality averaging 4, data they bring to their gynecologist to support a hormone therapy evaluation.
• Person currently on hormone therapy evaluating dosage — Someone on existing HRT tracks Treatment Effect at 4 out of 10 over four weeks alongside continued night sweat severity of 7, evidence they bring to their prescriber for a dose adjustment discussion.
• Person transitioning through perimenopause — A person in early perimenopause tracks irregular symptoms for three months and discovers their symptom intensity correlates with cycle phase, giving their provider a pattern to work with rather than treating symptoms as random.
• Person comparing non-hormonal options — Someone who cannot use hormone therapy tracks symptom burden before and after starting a non-hormonal prescription, comparing average hot flash frequency and Treatment Effect scores across the two four-week periods.

Key terms

Hot flash

An acute episode of intense warmth, flushing, and typically sweating, driven by vasomotor instability associated with estrogen decline. Tracked daily as both a count and severity rating.

Night sweats

Nocturnal hot flash events significant enough to disrupt sleep, sometimes involving drenching sweats. Tracked on a 0-to-10 scale separately from daytime hot flashes because their primary impact is on sleep quality.

Vasomotor symptoms

The clinical term for hot flashes and night sweats in menopause, driven by the effect of declining estrogen on the hypothalamic temperature regulation system.

Treatment effect

A 0-to-10 self-rating of how much relief your current treatment approach is providing across your overall symptom burden. Tracked daily alongside symptom scores to evaluate whether the current approach is sufficient.

Sources & further reading

• NAMS — Menopause.org For Women
• ACOG — The Menopause Years FAQ
• Office on Women's Health — Menopause
• National Institute on Aging — Menopause
• PubMed — 2022 NAMS Hormone Therapy Position Statement